Clinical Trial

Biomarkers in Inflammatory Rheumatic Diseases Diagnosis

Study acronym: BIRDD
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 20, 2025 (before its estimated March 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Ankylosing spondylitis (AS), Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) are three diseases where early diagnosis remains a major challenge. However, early diagnosis is the main determinant for a better prognosis. In the early stage, symptoms may be nonspecific and often difficult to establish a differential diagnosis between rheumatic diseases and other diseases, namely infectious and cancer diseases.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-10.
Trial Details
NCT Number NCT06778343
Lead Sponsor Universidade Nova de Lisboa
Collaborators: Centro Hospitalar Lisboa Ocidental
Conditions Ankylosing Spondylitis, Rheumatic Arthritis, Systemic Lupus Erythematosus
Enrollment 134 participants
Start Date 2023-01-31
Primary Completion 2025-03-31 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-01-20